ASH 2024 Summary: Highlights in Bone Marrow Failure Disorders

2024 ASH Annual Meeting Insights Hub

P. Scheinberg

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Is There a Role for Splenectomy in ITP?

Platelet Disorder Support Association (PDSA)

C. Kessler

Current Treatment Guidelines for ITP: Individualized Therapy and Eme…

Irina Murakhovskaya

PKD: Diagnosis, Treatment and Monitoring for Complications

Stanford Medicine

M. Chien

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Mitapivat in PKD: Results of the ACTIVATE Trial and Updated Treatmen…

Stefan Eber

Switching ITP Patients to Avatrombopag From Other TPO-RAs: When to D…

Keck School of Medicine of USC

H. Liebman

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

Diagnosis and Testing Considerations for Cold Agglutinin Disease

Julia Cunningham

PKD Epidemiology, Diagnosis, and Management

Stefan Eber

Natural History of ITP: Navigating the Journey

Platelet Disorder Support Association (PDSA)

D. Kuter

Are All New ITP Treatments Better Than Old Ones: Other Treatments to…

Platelet Disorder Support Association (PDSA)

H. Liebman

Management of iTTP

Yazan Abou-Ismail

Evolving Treatment Landscape in ITP

Robert Bird

CAD: The Basics and Development

Kelly Davidson